key: cord-1027984-yo8ures3
authors: Tibbels, Natalie; Dosso, Abdul; Fordham, Corinne; Benie, William; Aka Brou, Jeanne; Kamara, Diarra; Hendrickson, Zoé; Naugle, Danielle
title: “On the last day of the last month, I will go”: A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults
date: 2022-02-11
journal: Vaccine
DOI: 10.1016/j.vaccine.2022.02.032
sha: 253a665489ec2218291d1e6e78c6922b306ead90
doc_id: 1027984
cord_uid: yo8ures3

The authorization of several high-efficacy vaccines for use against the novel SARS-CoV2 virus signals a transition in the global COVID-19 response. Vaccine acceptance is critical for pandemic control and has a variety of context- specific drivers that operate at the individual, group, and sociopolitical levels. Social and behavior change interventions can influence individual knowledge, attitudes, and intentions as well as community norms to facilitate widespread vaccine uptake. While considerable research has been done to explore vaccine confidence in high-income populations as well as with respect to childhood vaccinations, much work remains to be done in understanding attitudes and intentions in low and middle income countries for adult or novel vaccines. We conducted in-depth interviews with individuals who had recovered from COVID-19 (n=8), people who had lost a family member to COVID-19 (n=4), and health providers (n=17). We also conducted focus group discussions with members of the general population (n=24 groups) to explore social norms and community perceptions related to COVID-19, including prevention behaviors, stigma, and vaccines. Researchers collected data in Abidjan, Côte d’Ivoire, in November 2020. In considering whether to accept a future COVID-19 vaccine or not, individuals in the study weighed perceived risk of the vaccine against the severity of the disease. Perceived severity of rumored side effects or safety issues of vaccines were also a factor. Convenience was a secondary, albeit also important, consideration. While concerns about vaccine safety tended to produce an expressed intention to delay vaccination, conspiracy theories about those developing and promoting vaccines and their motives led people to say they would opt out entirely. Behavior change interventions must raise awareness and address misunderstandings about the purpose of vaccines, transparently communicate about vaccine safety and development processes, and engage trusted influencers to build an enabling environment for COVID-19 vaccine roll out.

The world passed 260 million documented cases of COVID-19 and 5.2 million deaths by late 2021. 1 The pandemic has had severe effects on health, with disruptions in routine health services as well as the direct effects of a COVID-19 case-fatality ratio that varies between 0.1% and 20% depending on the country context. 2, 3 The authorization of several high-efficacy vaccines for use against the novel SARS-CoV2 virus signals a transition point in the management of the COVID-19 pandemic. 4 While demand will continue to outpace supply for some time, equitable vaccine distribution hinges on addressing vaccine confidence among hesitant populations. Based on a reproduction rate (Ro) of 2.2, at least 60% of people in a given setting will need to be vaccinated or have natural immunity to achieve epidemic control, with recent estimates up to 90%. 5, 6 The emergence of more transmissible variants may increase the proportion of the population that must be vaccinated or achieve immunity through natural infection. 7

Vaccine hesitancy is an individual decision to delay or avoid vaccines that are available, and it has a variety of drivers that operate at the individual, interpersonal, and contextual levels. 8, 9 These drivers are commonly grouped into three categories called the "three Cs" framework: complacency, confidence, and convenience. 10 Complacency is the group of factors related to perceived risk and severity of the illness -whether people believe they will be infected or that the virus will be serious if they are infected -that influence the motivation to protect oneself through a vaccine. Confidence encompasses beliefs about the ability of the health system and health providers to offer a safe vaccine, to behave in a trustworthy manner, or to have benevolent motives. Convenience summarizes factors around cost of the vaccine, ability to understand when one is eligible and how to obtain the vaccine, and whether vaccines are delivered in a culturally acceptable or convenient place. Individual factors (knowledge, beliefs, attitudes, sociodemographic characteristics) intersect with issues at the structural level (vaccine supply, costs, modes of delivery, history, and policies) and together influence confidence and complacency. 11 A 2020 report from the World Health Organization (WHO) frames these types of drivers of vaccine hesitancy in terms of whether there is an enabling environment, and then also examines social influences such as norms and the media environment. 8, 12 In the case of COVID- 19 , the extent of misinformation about the virus and associated vaccine development is complex and unprecedented, with rumors circulating widely that minimize the existence or threat of the virus itself and the safety of the vaccines. 13, 14 Intention to be vaccinated against occurs within the context of abuses in medical research and intractable distrust in governments. [15] [16] [17] [18] [19] In April 2020, controversial statements from scientists about vaccine trials in Africa led to widespread condemnation of a colonial mindset that would consider African volunteers as "guinea pigs." 20 The pandemic and related rumors have reduced coverage and acceptance of routine services including immunizations, a catastrophic outcome causing untold collateral damage to children and youth. 3, 21, 22 In Côte d'Ivoire, for example, less than half of people in an online survey reported that they would accept the vaccine if available, while rumors and conspiracy theories circulated about the origin and response to COVID-19 and the safety of vaccines. 23, 24 In spring 2021, Côte d'Ivoire received half a million doses of the AstraZeneca vaccine through the COVAX program and moved through a phased roll-out, beginning with health workers, teachers, security and military, followed by international travelers, people over age 50, and those with chronic illnesses or preexisting conditions that put them at higher risk, and, finally, the general public -yet uptake lagged. 25, 26 In the long term, addressing the structural inequities and socio-economic and political factors that undermine trust in the public health response is critical for creating an enabling environment for vaccine roll-out. 11 In the short term, however, social and behavior change (SBC) interventions are needed to influence individual knowledge, attitudes, and intentions as well as community norms to facilitate widespread vaccine uptake. 27 Risk communication and community engagement (RCCE) interventions draw on SBC approaches to address population fears, build trust in health providers and public health responders, and partner with trusted local influencers to promote positive attitudes and norms toward specific behaviors that prevent disease transmission. Critical to successful RCCE is a nuanced understanding of context-specific knowledge, attitudes, beliefs, intentions, and norms that precede and enable protective behaviors. 27,28 While considerable research has been done to explore vaccine confidence in highincome populations as well as with respect to childhood vaccinations against diseases like polio or measles, there remains a need to understand the nuances and lived realities of those in low and middle income countries (LMICs), particularly for novel and adult vaccinations. 29 Apart from a few recent online surveys in the region, the specific factors influencing vaccine confidence toward COVID-19 vaccines specifically in Côte d'Ivoire are not well understood. 30, 31 In light of these ongoing gaps, the USAID-funded [project name anonymized] project conducted a study to investigate perceptions of and barriers to accepting a COVID-19 vaccine among health workers and the general population in Côte d'Ivoire. Data were collected as part of a larger qualitative study on stigma related to COVID-19 implemented in late 2020, before COVID-19 vaccines were available in Côte d'Ivoire. This analysis was conducted to identify perspectives on COVID-19 vaccines from those who had direct exposure to COVID-19 as well as those who did not to inform programmatic efforts promoting vaccine uptake in Côte d'Ivoire.

We conducted in-depth interviews (IDIs) with individuals who had recovered from COVID-19, people who had lost a family member to COVID-19, and health workers (some of whom had also survived COVID-19). Health workers were included both as key informants on COVID-19 related topics and as potentially stigmatized individuals due to perceptions around elevated risk of exposure among health workers to COVID-19. Health workers are among the earliest eligible for the COVID-19 vaccines and may have insight on their own or their patients' vaccine confidence. Health workers included doctors, nurses, and other providers (such as pharmacists) who worked at COVID-19 treatment centers or participated in rapid response teams as well as health workers who did not work in COVID-19 units. We differentiated between those who had treated COVID-19 patients and those who had not, to explore whether proximity to COVID-19 patients affected their perceptions or experience of COVID-19 stigma. We also conducted focus group discussions (FGDs) with members of the general population to explore social norms and community perceptions related to COVID-19, including prevention behaviors, stigma, and vaccines. Sample size was determined based on standard guidance for qualitative research. 32, 33 Focus groups were mixed gender, age, and educational background. Participants were men and women over the age of 18.

We used purposive sampling to recruit participants with the help of focal persons at COVID-19 testing and treatment centers and in communities using standard recruitment scripts. Participants were recruited in four COVID-19 treatment centers set up by the government for the management of COVID-19 patients in Abidjan. Study collaborators within the Ministry of Health tasked with follow up of COVID-19 patients recruited participants based on the criteria outlined in the research protocol. During the recruitment process, participants were asked a set of questions to determine their experiences with COVID-19. If they had survived COVID-19 themselves or had lost a family member to COVID-19, they were invited to participate in IDIs.

Health workers were invited to participate in IDIs regardless of whether they had survived COVID-19 or treated COVID-19 patients. All others were invited to participate in FGDs, with separate FGDs for those who indicated they knew someone personally who had had a positive COVID-19 test. FGD participants came from six distinct neighborhoods in Abidjan. Analysis. The research team facilitated a five-day participatory data analysis workshop, gathering 14 people including the interviewers, representatives from the national government, and staff from the [project name anonymized] research and programmatic teams. During the workshop, participants read sections of transcripts and discussed themes and insights in small groups. They then presented their insights to the large group, and the entire team consolidated themes and gathered illustrative quotations to identify key insights. Following this preliminary thematic analysis, the interviewers coded the transcripts using a codebook informed by the interview guides (deductive) as well as by insights from the analysis workshop (inductive). The coding team double-coded 19% of transcripts, meeting to resolve discrepancies and ensure standard application of the codes. During the data analysis workshop and subsequent coding and analysis, saturation was determined to have been reached given that themes were recurring across transcripts. The current analysis looks at the subset of data related to vaccine knowledge, attitudes, and norms. Data related to COVID-19 vaccination were read, synthesized into themes and then organized according to the 3 Cs theoretical framework.

A total of 156 individuals participated in this qualitative study as outlined in Table 1 . We conducted 29 IDIs and 24 FGDs (with 127 FGD participants). There were 89 men and 67 women. Seventeen of the IDIs were with health workers. In the following sections, we examine perceptions of vaccines against the SARS-CoV2 virus by exploring various ideational factors that serve as barriers to vaccination. We also identify specific facilitators that participants indicated might motivate them to voluntarily accept the vaccine.

Just as the literature identifies three categories of determinants of vaccine hesitancycomplacency, confidence and convenience -we found that the participants in our study weighed perceived severity of rumored side effects or safety issues (confidence) against perceived risk This same participant directly linked this conspiracy theory to an opt-out form of hesitancy rather than an intention to delay, going on to say,

An individual who had recovered from COVID-19 said, "People say that the vaccine doesn't allow you to have children, that it is something they are experimenting with once again"

(COVID-19 survivor, male) and went on to say that he would not be "ready" to get the vaccine because of the rumor. The "once again" in the quotation is a striking commentary on the history and legacy of mistrust and exploitation during scientific research lingering in the minds of participants. problem" (health worker, female). Another health worker cited a desire to protect family members from COVID-19, saying "I'm a health worker, exposed, super exposed… so I will get vaccinated to protect myself and to protect my family" (health worker, male). Other participants similarly described vaccines as a way to protect others, rather than themselves.

At the same time, participants rarely mentioned the concept of a vaccine until specifically asked.

Though a variety of COVID-19 prevention and treatment methods were covered during the discussions, vaccines were not spontaneously mentioned. One participant who had lost a family member to COVID-19, once prompted, indicated he would probably not get the vaccine, saying, "I don't think so, I haven't really thought about it yet" (individual who lost a family member, male). Once directly asked, people frequently misunderstood or mischaracterized the purpose of vaccination. One participant said that "if the person doesn't have COVID, they will refuse because they will surely say that they are healthy, why go? They're not sick. Why go to the hospital?"(general population, male). One person who had recovered from COVID-19 pointed out the reduced risk perception, saying that early in the pandemic, "we took it very seriously because we were a little bit afraid, but now everything has returned to normal. So we say, ok, that's something that has passed, so I don't think about it much." (COVID-19 survivor, male)

He went on to say that the disease is "no longer scary" and that he would probably not get the vaccine. The waning risk perception illustrated by this quotation intersects with health workers' observations that patients who had been avoiding routine vaccinations are now returning.

People in FGDs also expressed a preference for treatment once sick as opposed to a vaccine that would prevent the illness. Participants -with the exception of health workers -at times thought the vaccine would function as a cure once sick. For those with low risk perception, the motivation to get a vaccine that might be unsafe or could have side effects was lower than awaiting a treatment that could cure them in the event they became infected.

Perceived severity of the illness. Besides occupational exposure or a sense of personal risk, the main reason many participants gave as a motivator for getting the vaccine was a sense of the seriousness of the illness. One health worker who had survived COVID-19 said she would get the vaccine "for fear of getting sick again, of getting this disease again" (health worker, female).

Another individual who had recovered from COVID-19 shared a proverb describing that someone who has seen a lion runs away faster than someone who has just heard tell of a lion, going on to explain, were seen by some participants as a way to avoid death and manage fear. One FGD participant said that "soon it will be one year that coronavirus, that COVID exists, so, today, no one wants to die, so we could accept the vaccine" (general population, male).

Financial access was a facilitator that participants mentioned, saying that the main thing needed for vaccine uptake is free access: "if it isn't too expensive or it is free, then people will accept it.

You will see the hospital will be full every day" (general population, female). The need for affordable and convenient access was a recurrent theme across health worker interviews and FGDs. Furthermore, the idea that a vaccine could enable a return to normal activities was appealing, with cost always in the background:

"Ivoirians like to be relaxed, have fun, be playful. So, I think that if a vaccine has been found, maybe the cost will deter some people, otherwise, if they say that there is a vaccine, right away, everyone will jump to get vaccinated." (general population, male)

The suggestion that the vaccine should be free was often framed, as in this quotation, not as the main determinant but a secondary or enabling factor for vaccine intention.

In summary, participants who expressed an intention to be vaccinated or thought others like them would get vaccinated cited as motivators perceived risk and perceived severity, a desire to protect others, and the possibility that vaccines would provide a way back to normalcy. Those who were "on the fence" about vaccination tended to be uncertain about the purpose of vaccines and had concerns about vaccine safety in light of the rapid development. Conspiracy theories and distrust in vaccine policymakers and distributors appeared to drive intention to refuse the COVID-19 vaccine. Convenience was typically mentioned as a recommendation that the vaccines be offered for free.

Consistent with other literature on vaccine hesitancy and recent surveys in the region, this study suggests that people who express resistance to COVID-19 vaccinations do so in part because they perceive the risk to be low (complacency) and/or they distrust the government as well as vaccine manufacturers and promoters (confidence). 8, 10 An online cross-sectional survey conducted in the Democratic Republic of Congo, for example, indicated that among respondents with low intention to receive a COVID-19 vaccine, barriers included lack of trust in the vaccine as well as beliefs that the vaccine was designed to kill or sterilized people in Africa. 31 The same study found that belief in the existence of COVID-19, a critical determining factor in one's perception of risk, was associated with vaccine acceptance. 31 Similarly, a recent study in

Cameroon identified barriers to vaccine confidence that correspond with our findings, including the influence of misinformation in traditional and social media, perceptions that pharmaceutical companies were profit driven and testing products in Africa, and questions about the testing and authorization processes for the vaccines. 30 This belief that COVID-19 is not a threat but COVID-19 vaccines are is strongly influenced by the communication environment and is a major barrier to vaccine acceptance.

Convenience also played a role with participants mentioning cost as a potential barrier, but convenience did not appear to be a primary factor in vaccine intention. With the exception of health workers, few participants in this study were aware of vaccination as a prevention method for COVID-19. In fact, vaccines were rarely top-of-mind for participants. While COVID-19 vaccines were not approved or available at the time of interviews, it does highlight the uphill battle that faces the vaccine roll-out as it begins to take shape across the world. 35 ." Yet the RCCE response often takes a fact or statement-based, institutional, biomedical approach. While accurate messaging may not be as sensational as conspiracy theories, vaccine messaging must strive for emotional resonance and salience, such as through testimonials and "leveraging anticipated regret". 12 This appeal promotes the belief that inaction may lead to a negative outcome (getting sick or infecting a loved one) which will lead to regret for having missed the opportunity to be vaccinated. 12 Communication and community engagement can influence perceptions and norms to the extent that trusted influencers are involved and the true concerns of the population addressed. 39, 40 Participants themselves underlined the need to consider who should deliver the messages about vaccines in order to convince those who are uncertain. One survey of social media users in Côte d'Ivoire in

November 2020 suggested that 53% of people would opt to take a COVID-19 vaccine if offered. 23 The same study indicated that the most influential group for those who were planning not to get the vaccine were friends and family, followed by the government (differentiated from politicians) and health workers. It is critical to engage local communities and local governments not only to influence beliefs, but to provide an enabling environment for vaccine uptake, such as government messaging on the fact that the vaccines are free and offering certificates of achievement for places of business where employees have all been vaccinated. Measures to communicate a social norm around vaccination, such as engaging journalists to showcase people being vaccinated, can lay the groundwork for vaccine roll-out in settings where mistrust is the current reality. Finally, we must complement SBC work with supply-side efforts to address accessibility, with a strong commitment to global vaccine equity.

The research team shared vaccine-related insights from this study with stakeholders in Côte d'Ivoire in order to demonstrate the need for awareness campaigns that would specifically address different barriers to vaccine confidence and uptake. The campaign is currently underway with the support of the [project name anonymized] project.

This study had several limitations. The main limitation was that it occurred at a particular point in time during a rapidly evolving pandemic, when perceptions and beliefs were changing in real time, and before COVID-19 vaccines were available in Côte d'Ivoire. However, situating the study eight months into the response allowed participants to reflect on their experiences during different phases and offer insights on vaccine confidence before the roll-out formally began.

Second, the study did not include rural locations. When data were collected, 95% of COVID-19

cases were in Abidjan, the capital of Cote d'Ivoire, where the study took place. 1 However, with resurgence of the virus because of new variants and economic reopening, rural settings may be increasingly affected by the pandemic. Future studies should take into account rural populations.

Third, the FGDs were mixed gender, and the analysis did not take into account differences in perspectives between men and women. Future research on vaccine acceptance in a setting like Côte d'Ivoire should prioritize and explore the influence of gender on study findings.

This study provides context-specific insight to barriers and motivators for COVID-19 vaccine uptake in Côte d'Ivoire. RCCE interventions must raise awareness and address misunderstandings about the purpose of vaccines, transparently communicate about vaccine safety and development processes, and engage trusted influencers to build an enabling environment for COVID-19 vaccine roll out.

An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases

Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. The Lancet Global Health

World Health Organization

What policy makers need to know about COVID-19 protective immunity. The Lancet

Phillips N. The coronavirus is here to stay-here's what that means

Mapping vaccine hesitancy-Countryspecific characteristics of a global phenomenon

Essential Programme on Immunization

Vaccine hesitancy: Definition, scope and determinants

Restoring confidence in vaccines in the COVID-19 era

Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report

Impact of rumors and misinformation on COVID-19 in social media

COVID-19-Related infodemic and its impact on public health: a global social media analysis

Is the colonial era still impacting people's health today? Gavi: The Vaccine Alliance

Nigerians to sue US drug company over meningitis treatment

Sterilizing vaccines or the politics of the womb: retrospective study of a rumor in Cameroon

Trust, fear, stigma and disruptions: community perceptions and experiences during periods of low but ongoing transmission of Ebola virus disease in Sierra Leone

Institutional trust and misinformation in the response to the 2018-19 Ebola outbreak in North Kivu, DR Congo: a population-based survey. The Lancet Infectious diseases

Coronavirus: France Racism Row Over Doctors' Africa Testing Comments. 2020. 21. Organization WH. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report

Missing during COVID-19 lockdown: Children with onset of type 1 diabetes

Johns Hopkins Center for Communication Programs, Massachusetts Institute of Technology, Global Outbreak Alert and Response Network, Facebook Data for Good

Real-Time Tracking of COVID-19 Rumors Using Community-Based Methods in Côte d'Ivoire. Global Health: Science and Practice

Covid vaccine campaign kicks off in Cote d'Ivoire

A Social and Behavioral Research Agenda to Facilitate COVID-19 Vaccine Uptake in the United States. Health security

Social networks, ideation, and contraceptive behavior in Bangladesh: a longitudinal analysis

Comparisons of vaccine hesitancy across five low-and middle-income countries

Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication

COVID-19 vaccine acceptance in the Democratic Republic of Congo: a cross-sectional survey

Can sample size in qualitative research be determined a priori?

Department of Health E. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research

India's vaccine rollout stumbles as COVID-19 cases decline

HIV vaccine trial participation in South Africa-an ethical assessment. The Journal of medicine and philosophy

Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines: interim guidance

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017

The CORE Group Partners Project in North East Nigeria: community engagement strategies to combat skepticism and build trust for vaccine acceptance. The American journal of tropical medicine and hygiene

The authors wish to thank the Ivorian individuals, particularly those who had fought COVID-19 themselves or lost family members to COVID-19, who were willing to share their experiences and insights. This paper was made possible with funds from the United States Agency for International Development (USAID) (Cooperative Agreement # AID-OAA-A-17-00017).

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.